Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants is a research paper published in Proceedings of the National Academy of Sciences (2022). On theSindex it has a DataRank of 0.730. It has been cited 129 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.730
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: AI124299
HHS | NIH | National Institute of Allergy and Infectious Diseases
Grant: AI149793
NIAID NIH HHS
Grant: R21 AI149793
NIAID NIH HHS
Grant: U01 AI124299
National Institutes of Health
Grant: 1R21AI149793-01A1
Mucosal Adjuvant to Induce Multipronged T Cell Immunity to Tuberculosis
National Institutes of Health
Grant: 5U01AI124299-04
Novel Combination Adjuvant for Eliciting Systemic and Mucosal CD8 T Cell Memory
FWCI
11.88
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals